Guest: Bilal Chughtai, MD
Advancements in diagnostics and treatment have led to enhanced personalized care for patients with benign prostatic hyperplasia (BPH) and overactive bladder (OAB). Minimally invasive treatments have the potential to replace medication for BPH, while a greater focus on bladder health can help differentiate the two conditions and improve outcomes. Learn how these advances are shaping BPH and OAB management with Dr. Bilal Chughtai, Chief of Urology at Plainview Hospital and Associate Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.
Clinician's Roundtable